Document is current
Any future updates will be listed below
-
Authors
Wong, Hon Jen
Teo, Yao Neng
Teo, Yao Hao
Syn, Nicholas L.
Wong, Andrea Li-Ann
Teoh, Hock-Leun
Seet, Raymond C. S.
Lee, Soo-Chin
Goh, Boon-Cher
Sia, Ching-Hui https://orcid.org/0000-0002-2764-2869
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00700895 at ClinicalTrials.govDocuments that mention this clinical trial
Subgroup analysis of genotype guided vs traditional warfarin dosing in Asian patients from an open label randomized trial
https://doi.org/10.1038/s41598-025-33831-9
-
Funding
Funding for this research was provided by:
ngapore Ministry of Health’s National Medical Research Council (NMRC/CSA/021/2010 and NMRC/CSA/0048/2013)
Biomedical Research Council of the Agency for Science, Technology and Research (A*STAR)
- License Information
-
More Information
Article History
Received: 12 March 2025
Accepted: 22 December 2025
First Online: 2 January 2026
Declarations
:
: The authors declare no competing interests.
: The ethics review committee at the Domain Specific Review Board of the National Healthcare Group approved the protocol (PG01/11/06). The study was conducted in accordance with Good Clinical Practice guidelines, and patients provided written informed consent prior to enrollment. All serious adverse events were reported to the Domain Specific Review Board and the Medical Clinical Research Committee, Ministry of Health in accordance with published guidelines. The study is registered at ClinicalTrials.gov (Identifier: NCT00700895 [19/06/2008]).
: Obtained as part of informed consent taking during the original study.
